Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02838108 · ClinicalTrials.gov registry record
The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 452
- Enrollment target
NCT02838108: Clinical Trial study, sponsored by Duke University.
NCT02838108 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 452 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02838108 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 452 participants
- Enrollment target
Study Summary
This is an observational study examining outcomes and treatment patterns in a community-based cohort of subjects with Chronic obstructive pulmonary disease (COPD) who are based in the Kannapolis, NC area.
Primary Outcome
Composite of COPD exacerbation, all-cause hospitalization, and all-cause mortality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-04-19 |
Why NCT02838108 stopped before completion
NCT02838108 is an observational study that tracks outcomes without assigning an intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02838108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02838108 about?
NCT02838108 is a clinical study titled "The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort". This is an observational study examining outcomes and treatment patterns in a community-based cohort of subjects with Chronic obstructive pulmonary disease (COPD) who are based in the Kannapolis, NC area.
What is the current status of trial NCT02838108?
This trial is currently terminated. The enrollment target is 452 participants. The study started on 2016-10. Estimated completion is 2018-04-19.
Who is sponsoring clinical trial NCT02838108?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia